IN2012DN02195A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02195A
IN2012DN02195A IN2195DEN2012A IN2012DN02195A IN 2012DN02195 A IN2012DN02195 A IN 2012DN02195A IN 2195DEN2012 A IN2195DEN2012 A IN 2195DEN2012A IN 2012DN02195 A IN2012DN02195 A IN 2012DN02195A
Authority
IN
India
Prior art keywords
administering
alone
subject
effective amount
therapeutically effective
Prior art date
Application number
Other languages
English (en)
Inventor
Yong Joon Jo
Yong-Jin Yang
Original Assignee
Kominox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox Inc filed Critical Kominox Inc
Publication of IN2012DN02195A publication Critical patent/IN2012DN02195A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/36Arsenic; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IN2195DEN2012 2009-09-18 2010-09-09 IN2012DN02195A (enrdf_load_stackoverflow)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24364809P 2009-09-18 2009-09-18
PCT/US2010/048314 WO2011034775A2 (en) 2009-09-18 2010-09-09 Methods for treating brain tumors

Publications (1)

Publication Number Publication Date
IN2012DN02195A true IN2012DN02195A (enrdf_load_stackoverflow) 2015-08-21

Family

ID=43756836

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2195DEN2012 IN2012DN02195A (enrdf_load_stackoverflow) 2009-09-18 2010-09-09

Country Status (15)

Country Link
US (1) US20110070314A1 (enrdf_load_stackoverflow)
EP (1) EP2477635A4 (enrdf_load_stackoverflow)
JP (1) JP2013505242A (enrdf_load_stackoverflow)
KR (1) KR20120048706A (enrdf_load_stackoverflow)
CN (1) CN102753188A (enrdf_load_stackoverflow)
AR (1) AR078170A1 (enrdf_load_stackoverflow)
AU (1) AU2010295841A1 (enrdf_load_stackoverflow)
BR (1) BR112012008310A2 (enrdf_load_stackoverflow)
CA (1) CA2772777A1 (enrdf_load_stackoverflow)
IN (1) IN2012DN02195A (enrdf_load_stackoverflow)
MX (1) MX2012002922A (enrdf_load_stackoverflow)
RU (1) RU2012108439A (enrdf_load_stackoverflow)
SG (1) SG179192A1 (enrdf_load_stackoverflow)
TW (1) TW201114431A (enrdf_load_stackoverflow)
WO (1) WO2011034775A2 (enrdf_load_stackoverflow)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2568834C2 (ru) * 2009-09-10 2015-11-20 Коминокс, Инк. Противораковая терапия, направленная против раковых стволовых клеток и форм рака, устойчивых к лечению лекарственными препаратами
KR101309036B1 (ko) * 2011-05-30 2013-09-16 주식회사 코미팜 방사선 민감도 증진용 약학 조성물
US8781202B2 (en) * 2012-07-26 2014-07-15 International Business Machines Corporation Tumor classification based on an analysis of a related ultrasonic attenuation map
US10076652B2 (en) * 2015-08-10 2018-09-18 Chang Gung University Method for ultrasound-mediated delivery system to monitor molecular penetration
KR20210016513A (ko) 2018-03-22 2021-02-16 코미팜 인터내셔널 오스트레일리아 피티와이 엘티디 메타 아비산염을 포함하는 약학 조성물 및 제조 방법
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물
KR20220020635A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 외용제 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1282218A (zh) * 1997-10-15 2001-01-31 波拉克斯生物药品 使用砷化合物治疗原发性及转移性肿瘤疾病的组合物及方法
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
DK2042182T3 (da) * 2002-04-10 2013-08-26 Komipharm Int Co Ltd Farmaceutisk sammensætning, der omfatter arsen, til behandling af malignitet.
WO2006104292A1 (en) * 2005-03-31 2006-10-05 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis

Also Published As

Publication number Publication date
AR078170A1 (es) 2011-10-19
EP2477635A4 (en) 2013-03-27
US20110070314A1 (en) 2011-03-24
RU2012108439A (ru) 2013-10-27
CA2772777A1 (en) 2011-03-24
EP2477635A2 (en) 2012-07-25
MX2012002922A (es) 2012-09-07
AU2010295841A1 (en) 2012-03-29
WO2011034775A3 (en) 2011-10-06
TW201114431A (en) 2011-05-01
CN102753188A (zh) 2012-10-24
WO2011034775A2 (en) 2011-03-24
SG179192A1 (en) 2012-05-30
BR112012008310A2 (pt) 2017-06-06
JP2013505242A (ja) 2013-02-14
KR20120048706A (ko) 2012-05-15

Similar Documents

Publication Publication Date Title
IN2012DN02195A (enrdf_load_stackoverflow)
AU2011328009A8 (en) Compounds and methods for treating pain
PH12013500543A1 (en) Breast cancer therapeutics
TN2013000227A1 (en) Use of sigma ligands in bone cancer pain
UA117451C2 (uk) Терапевтично активні сполуки і способи їх застосування
MX2020004689A (es) Tratamiento del cancer con inhibidores de tor cinasa.
MX2011008221A (es) Tratamiento de cancer de pulmon con un compuesto de nitrobenzamida en combinacion con un inhibidor de un factor de crecimieno.
EP2582682A4 (en) METHOD FOR THE TREATMENT OF LUNG DISEASES
MX2020010004A (es) Composicion farmaceutica que comprende empagliflozina, metodos para tratamiento y sus usos.
MY191932A (en) Chitosan-derived compositions
PH12015501002A1 (en) Treatment of cancer with pomalidomide in a renally impaired subject
SG191060A1 (en) Robo1-fc fusion protein for use in the treatment of hepatocarcinoma
PH12015500867A1 (en) Treatment of prostate cancer with tor kinase inhibitors
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
MX348412B (es) Métodos de usar sns-595 para el tratamiento de sujetos con cáncer con actividad reducida de brca2.
PH12015501113A1 (en) Combination therapy with volasertib
SG179069A1 (en) Cancer stem cell-targeted and drug resistant cancer therapy
MX2016001084A (es) Volasertib en combinacion con decitabina para el tratamiento de leucemia mieloide aguda y sindrome mielodisplasico.
MX357770B (es) Ácidos nucleicos de enlace sdf-1 y el uso de los mismos en el tratamiento de cáncer.
HK1168030A (en) Methods for treating brain tumors
PH12014502464A1 (en) Veliparib in combination with whole brain radiation therapy for the treatment of brain metastases
AR087392A1 (es) Combinacion antitumoral que comprende ombrabulina y cisplatino, asociada a radioterapia
WO2013040504A3 (en) Srpx for treatment of cancer